— ABOUT AEVON CORPORATION

Building the infrastructure
for the next medical era

Aevon Corporation is an AI-driven biotechnology company at the intersection of artificial intelligence and life sciences — transforming healthcare from reactive treatment into proactive, data-driven longevity science.

5
Core focus domains
AI
Driven research
4D
Anatomical modelling
?
Healthspan ambition

Mission & Vision

Guiding our journey toward a healthier future

Our Mission

To extend human lifespan and improve quality of life through the integration of artificial intelligence and cutting-edge biomedical research — detecting disease before it appears, optimising health at every stage of life.

Our Vision

A future where aging is not inevitable decline, but a manageable biological process. Through predictive models, biomedical innovation, and intelligent systems, we are redefining how humanity approaches health, disease, and longevity.

Traditional healthcare treats disease AFTER it occurs. We are building systems that shift this model toward PREVENTION, prediction, and long-term health optimisation.

Founders

Ranjit Yadav

Ranjit Yadav

Founder & Research Lead

Interested in artificial intelligence, biotechnology, and longevity research. Leads team activities, research planning, ...

Aarohi Shekhawat

Aarohi Shekhawat

Co-Founder & Research Coordinator

Research Management, Content Writing & Data Collection
Interested in research, scientific writing, and knowledge manage...

Executive Leadership

Nasim Islam

Nasim Islam

Co-Founder

Research & Science

Rahul Singh

Rahul Singh

AI & Data Science Member

AI Research & Data Analysis
Interested in artificial intelligence, machine learning, and data science. Supports technic...

Pooja Shaw

Pooja Shaw

Biotechnology Research Member

Human Biology & Health Research
Interested in human biology, health, and longevity. Helps study biological processes an...

Anjali Yadav

Anjali Yadav

Biotechnology Research Member

Scientific Literature & Research Analysis.
Interested in biotechnology and scientific discovery. Helps review research ...

Rohan Singh

Rohan Singh

Biotechnology Research Member

Biotechnology & Longevity Research
Interested in biotechnology, human health, and aging research. Supports scientific r...

Core Focus Areas

Where we concentrate our research and development efforts

Artificial Intelligence in Healthcare

Developing intelligent systems for clinical decision support, biomedical discovery, and automated pattern recognition across large-scale biological datasets.

Predictive Medicine & Early Detection

Creating algorithms to identify health risks before symptoms appear — shifting medicine from intervention to anticipation at the individual level.

Longevity Research & Aging Biology

Investigating the biological mechanisms of aging — cellular senescence, mitochondrial dysfunction, epigenetic drift — to enable measurably healthier lifespans.

Data-Driven Health Systems

Building infrastructure for integrated, real-time health intelligence — unifying biomarker data, imaging, genomics, and longitudinal tracking at scale.

Future Medical Infrastructure

Designing next-generation platforms for proactive and preventive care — the backbone of a healthcare system built for the 22nd century.

Why Aevon Corporation

What sets us apart in the biotechnology landscape

01

Proactive, not reactive

We build systems that anticipate disease before it develops — not tools to manage illness after the fact.

02

Evidence-first philosophy

Every platform, model, and research programme is grounded in peer-reviewed science and rigorous data analysis.

03

AI × biomedical integration

We sit at the unique intersection of artificial intelligence and life sciences — a combination most institutions treat separately.

04

Open collaboration model

Research portals, open literature, and a formal collaboration framework — we grow by sharing, not hoarding.

05

Systemic scope

From subcellular biology to population-level epidemiology — our work spans every level of biological organisation.

06

Long-term horizon

We think in decades and centuries, not quarterly cycles — building infrastructure that outlasts any single breakthrough.

The Aevon Platform

Integrated approach to longevity science

Human Repair Index

Predictive health scoring system

Body Flux

4D anatomical database

Research Portal

Open longevity literature

Longevity Science

Evidence synthesis engine

Collaborations

Open research partnerships

Our Journey

Milestones that define our path forward

Foundation

Foundation of Aevon Corporation

Aevon Corporation was founded with the vision of advancing artificial intelligence, biotechnology, and longevity science to build the infrastructure for the next medical era

Year/Label: 2026

Trademark Application Filed

Filed the ÆVON CORPORATION trademark application (Application No. 7660908) under Class 42 with the Trade Marks Registry, Government of India. The application covers artificial intelligence research and development, software development, web application development, digital platform services, and technology-based solutions.

Year/Label: 2026

MSME Registration Obtained

Aevon Corporation received MSME registration (Registration No. WB-14-0268466), recognizing the organization as a registered Indian enterprise and strengthening its foundation for innovation, technology development, and future business growth.

Early Research

Longevity Science platform launched

Published the first evidence synthesis on cardiovascular risk, VO? max, and muscle mass as primary longevity predictors.

Infrastructure

Body Flux — 4D anatomical database

Released the complete 4D anatomical systems database mapping 12 organ systems, 78 organs, 206 bones, and 640+ muscles.

Research

Open Research Portal goes live

Launched an open literature portal for longevity and AI-driven biomedical research with public collaboration access.

2026

Platform Expansion

Growing the Human Repair Index, deepening research partnerships, and scaling infrastructure for the next generation of proactive healthcare.

Q1 2026

ÆVON LifeScore

Lifestyle-based health score with biological age estimate and prioritized insights

Q2 2026

Launch of Risk Insights Engine

Introduction of Aevon’s first functional system—Risk Insights. This engine analyzes lifestyle and basic health data to highlight potential cardiovascular and metabolic risks, enabling early awareness without clinical complexity

2026 — Genesis Phase

Foundation of Aevon Intelligence

Aevon enters its Genesis Phase, laying the groundwork for a next-generation longevity intelligence system. Initial development focuses on transforming everyday health inputs into structured, actionable insights, marking the beginning of Aevon’s core architecture.

Important clarification: Aevon Corporation is an independent organization and has no affiliation, association, or endorsement relationship with any similarly named companies, including Avon or Aeon. All official operations are conducted solely under the Aevon Corporation brand via aevoncorp.com.

Explore Aevon

Connect with us across platforms

Website Medium Dev.to Crunchbase GitHub Instagram LinkedIn Facebook GoodFirms Clutch PatSnap Glassdoor AmbitionBox Wellfound Google Profile YouTube X Product Hunt Kaggle Hugging Face F6S StartupBase Indeed Substack GitLab Zenodo

Get in Touch

Reach out to learn more about our work

General inquiries
info@aevoncorp.com
Research collaboration
Submit a request ?
Investors
Investor relations ?
Collaborators
Join our network ?